Renal Diseases Market Reports Empesis on Targeting Immune and Hormone Signaling Dominating the Pipeline for Chronic Kidney Disease

The Frontier Pharma: Renal Diseases High Degree of Innovation and Diversity with Products Targeting Immune and Hormone Signaling Dominating the Pipeline for Chronic Kidney Disease assesses first-in-class innovation in the renal diseases pipeline, highlighting key trends and emerging treatment classes.

Pune, India - March 14, 2018 /MarketersMedia/ —

The renal diseases therapy area encompasses a range of diseases of the kidney, such as chronic kidney disease (CKD), acute kidney injury, diabetic nephropathy and focal segmental glomerulosclerosis. Renal diseases are becoming increasingly common due to the increased prevalence of hypertension and diabetes, two major causes of CKD. For most forms of renal diseases, early detection and management may slow down or prevent progression to renal failure and associated complications. However, many renal diseases are typically asymptomatic until they have progressed to end-stage renal disease (ESRD), which requires renal replacement therapies such as hemodialysis and renal transplantation, and is associated with substantial morbidity and mortality.

Access Report Details at: https://www.themarketreports.com/report/frontier-pharma-renal-diseases-high-degree-of-innovation-and-diversity-with-products-targeting-immune-and-hormone-signaling-dominating-the-pipeline-for-chronic-kidney-disease

The first-in-class programs identified show considerable diversity, and the relatively high degree of innovation in the renal diseases therapy area makes for a promising development pipeline. It is clear that recent activity in this area has increased, partly owing to the growing recognition of the unmet medical need. Further investment in innovation would benefit the therapy area greatly, and likely prove a worthwhile investment, particularly for highly prevalent diseases such as CKD and diabetic nephropathy, for which there are a lack of effective pharmacotherapeutic options.

Get this report at: https://www.themarketreports.com/report/buy-now/935551

Scope
• With 365 products in active development, the pipeline is modestly sized. Does current pipeline innovation hold the potential to affect the future renal diseases market?
• There are 100 first-in-class products in the renal diseases pipeline. Which of these hold the greatest potential to improve future disease treatment with regard to their molecular target?
• The majority of first-in-class products were in development for indications involving inflammation. Which first-in-class targets are most promising, and how does the ratio of first-in-class targets to first-in-class products differ by stage of development and molecular target class?
• A significant number of first-in-class products have been identified with no prior involvement in deals. How do deal frequency and value compare between target families and molecule types, and which first-in-class programs have not yet been involved in a licensing or co-development deal?

Inquire for more details at: https://www.themarketreports.com/report/ask-your-query/935551

Contact Info:
Name: Shirish Gupta
Email: sales@themarketreports.com
Organization: The Market Reports
Address: SF-29, Sacred World, Wanawadi
Phone: 16314071315

Source URL: https://marketersmedia.com/renal-diseases-market-reports-empesis-on-targeting-immune-and-hormone-signaling-dominating-the-pipeline-for-chronic-kidney-disease/314328

For more information, please visit https://www.themarketreports.com/report/frontier-pharma-renal-diseases-high-degree-of-innovation-and-diversity-with-products-targeting-immune-and-hormone-signaling-dominating-the-pipeline-for-chronic-kidney-disease%20%20

Source: MarketersMedia

Release ID: 314328

Latest News

Pompeo: No end to NKorea sanctions until 'denuclearization'

Sep 23, 2018

NEW YORK — Top U.S. diplomat Mike Pompeo said Sunday that economic sanctions on North Korea won't be reduced until it completes "denuclearization" after leader Kim Jong Un offered to close the North's main nuclear site in exchange for U.S. concessions. Kim said last week at a summit with South Korea's president that he was willing to dismantle the Nyongbyon nuclear complex in the presence of outside inspectors if the U.S. takes unspecified "corresponding measures." He also promised to dismantle the North's main rocket launch site. That has helped revive U.S.-North Korea diplomacy that had failed to make headway since...

At UN, unrepentant Trump set to rattle foes, friends alike

Sep 23, 2018

BRIDGEWATER, N.J. — President Donald Trump is poised to redouble his commitment to "America First" on the most global of stages this week. In the sequel to his stormy U.N. debut, Trump will stress his dedication to the primacy of U.S. interests while competing with Western allies for an advantage on trade and shining a spotlight on the threat that he says Iran poses to the Middle East and beyond. One year after Trump stood at the rostrum of the U.N. General Assembly and derided North Korea's Kim Jong Un as "Rocket Man," the push to denuclearize the Korean Peninsula...

Meghan reveals 'something blue' she wore at royal wedding

Sep 23, 2018

LONDON — It's an old tradition that a bride should have something old, something new, something borrowed and something blue on her wedding day, and the Duchess of Sussex followed at least part of that when she married Prince Harry. The former Meghan Markle has revealed in a television documentary that she had a piece of blue fabric from the dress she wore on her first date with Harry sewn into her wedding dress. She made the comments while discussing the dress in a documentary about Queen Elizabeth II called "Queen of the World." She didn't say whether she also...

Dolce&Gabbana explore DNA with star-filled cast

Sep 23, 2018

MILAN — Milan designers are embracing women of all shapes, sizes and ages, even if the young, thin model prevailed during this week's previews for next spring and summer. Marni's runway included women of different sizes while Dolce & Gabbana continued their embrace of models in a range of ages and sizes for their DNA runway show on Sunday. Highlights from Sunday's show, the fifth day of previews of womenswear for next spring and summer: DOLCE & GABBANA PAY TRIBUTE TO HERITAGE Dolce & Gabbana retraced their DNA by bringing back some of their most famous models: Carla Bruni in...

As aid checks go out, farmers worry bailout won't be enough

Sep 23, 2018

WASHINGTON — Farmers across the United States will soon begin receiving government checks as part of a billion-dollar bailout to buoy growers experiencing financial strain from President Donald Trump's trade disputes with China. But even those poised for big payouts worry it won't be enough. And while support for Trump is near unwavering in the heartland, some growers say that with the November election nearing, such disappointing aid outcomes could potentially affect their vote. "It's pretty obvious that the rural agriculture communities helped elect this administration, but the way things are going I believe farmers are going to have to...

Search

Obserworld delivers the most accurate and up-to-date world news for the global audience with a thorough research and in-depth interviews. Discover the world through Obserworld.

Contact us: sales[at]obserworld.com